Expensive large-scale trials on no-hoper drugs could become a thing of the past after a European research collaboration worked out how to tell if a medication is likely to cause side effects before they actually appear.
Apr 7, 2017
0
4
A legal academic and health law expert is calling for a change in the law to protect all New Zealanders who are injured during clinical trials.
Jan 31, 2017
0
0
From reading and hearing news accounts, the general public has a vague impression that some things are amiss with the pharmaceutical industry—one word: Epipens. But few might consider it an industry in a state of collapse.
Jan 12, 2017
0
49
The Philippine Food and Drug Administration said Tuesday that it has ordered pharmaceutical giant Sanofi Pasteur Inc. to stop airing television and radio advertisements for its dengue vaccine in violation of a ban on promoting ...
Jan 3, 2017
0
0
Staggering hikes as high as 5000% in prices of some prescription drugs threaten the health of Americans who can't afford vital medicines as well as the broader economic stability of households across the U.S., a new congressional ...
Dec 26, 2016
1
8
One drug, one disease. This is how we traditionally think about pharmaceutical drugs, but many of them are actually effective for more than one disease.
Nov 29, 2016
0
0
The makers of prescription painkillers have adopted a 50-state strategy that includes hundreds of lobbyists and millions in campaign contributions to help kill or weaken measures aimed at stemming the tide of prescription ...
Sep 18, 2016
0
6
The rising price for EpiPens, a drug delivery system that is crucial for persons experiencing potentially life-threatening allergic reactions, has resulted in outrage. The price increase, from about US$94 for a two-pack of ...
Aug 25, 2016
0
1
Researchers at the Skaggs School of Pharmacy and Pharmaceutical Sciences at CU Anschutz have developed a technique that estimates an HIV-negative patient's adherence to drugs prescribed to prevent HIV transmission during ...
Aug 23, 2016
0
4
Ophthalmologists who receive money from pharmaceutical companies are more likely to prescribe medications promoted by those companies than similar drugs that are less costly, a new study shows.
Aug 18, 2016
0
1
